Company intelligence / Profile preview

BioIVT

New York, New York, United Statesbioivt.com ↗

Ownership: Private
Employees: ~750
Development stage: Commercial

Overview

BioIVT specializes in providing high-quality human and animal biospecimens—including tissues, blood products, cell lines—and value-added services such as hepatic modeling solutions. Their offerings support drug discovery and development workflows including ADME-Tox studies. They are recognized as a leading supplier to biopharma companies seeking clinical specimens with comprehensive data[1][2][3][4][5].

Therapeutic areas: Other
Modalities: Small moleculeBiologicCell therapyProtein
Industry: Non-Drug Biotech

Partnerships

No specific partnerships listed; collaborates broadly with biopharma/diagnostic/biotech clients globally

Beyond the preview

Go deeper on BioIVT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioIVT.

Explore the full profile